Keywords: amarin, licenses, nasal, lorazepam, elan, london, uk-based

Amarin licenses nasal lorazepam from Elan

Article | 12 March 2007

Print This

London, UK-based Amarin Corp has acquired a global license to develop and market Irish drugmaker Elan's novel, nasal lorazepam formulation ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in